The world’s first nasal vaccine for COVID-19 was approved Sept. 6 in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University and developed in collaboration with Bharat Biotech International Limited in India.
Ismael Seáñez received a five-year $1 million grant from the National Institutes of Health (NIH) to lead interdisciplinary spinal cord injury research.
Washington University in St. Louis has partnered with Handshake, a career management platform, to better help students and alumni discover new career paths and find jobs and internships. Handshake replaces CAREERlink.
Men with low testosterone who develop COVID-19 are at elevated risk of becoming seriously ill and ending up in the hospital, according to a study by researchers at Washington University School of Medicine and Saint Louis University School of Medicine.
Vijay Ramani at the McKelvey School of Engineering is one of 15 new fellows of the Electrochemical Society, recognized for his contributions to the field.
Jianjun Guan at the McKelvey School of Engineering was awarded a four-year $1.8 million grant from the National Institutes of Health (NIH) to develop a new dressing for chronic wounds in people with diabetes.
Senior Amanda Sherman is back to ambush — ahem, interview — Washington University in St. Louis students (and a WashU canine) about the new academic year.
A new study from Washington University School of Medicine suggests a simple blood test — administered before CAR-T cell treatment is initiated — may identify which patients are predisposed to developing neurotoxic side effects after CAR-T cell therapy, which is used to treat several cancers.
